Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-04
1989-09-05
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548534, A61K 900, A61K 3140
Patent
active
048639524
ABSTRACT:
A composition for percutaneous drug administration which contains a compound of the general formula ##STR1## wherein R.sub.1 is a hydrogen atom or an alkyl group and R.sub.2 is a residue of aliphatic hydrocarbon.
The composition is capable of promoting percutaneous drug absorption.
REFERENCES:
patent: 3836665 (1974-09-01), Eberhardt et al.
patent: 3920814 (1975-11-01), Bocher et al.
patent: 3975399 (1976-08-01), DeFranco et al.
patent: 4394380 (1983-07-01), Hassain et al.
patent: 4428883 (1984-11-01), Hassain
Zoretic et al., J. Hetero. Chem., 14 pp. 1267-1269 (1977).
Abe Yoko
Itoh Yoshiaki
Satoh Susumu
Nitto Electric Industrial Co. Ltd.
Springer David B.
LandOfFree
Method of promoting percutaneous drug absorption with 2-pyrrolid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of promoting percutaneous drug absorption with 2-pyrrolid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of promoting percutaneous drug absorption with 2-pyrrolid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243823